Article
Reliability of bioimpedance and indirect calorimetry to evaluate resting metabolic rate in brazilian women with metabolic syndrome
Registro en:
BENTES, Claudio Melibeu et al. Reliability of bioimpedance and indirect calorimetry to evaluate resting metabolic rate in brazilian women with metabolic syndrome. Diabetes and Metabolic Syndrome: Clinical Research and Reviews, v. 15, n. 2, p. 493-497, Mar./Apr. 2021.
1871-4021
10.1016/j.dsx.2021.02.018
1871-4021
Autor
Bentes, Claudio Melibeu
Silveira, Anderson Luiz Bezerra da
Di Masi, Fabrízio
Netto, Claudia
Marinheiro, Lizanka Paola Figueiredo
Resumen
Research and Development Foundation of Rio de Janeiro State (FAPERJ) Programa Pesquisa para o SUS Coordination of Improvement of Higher Education Personnel (CAPES/Brazil) Background and aims: Precise evaluation of resting metabolic rate (RMR) is critical, especially for seniors in syndromes conditions. The study aimed to compare different methods and devices to evaluate the resting metabolic rate and assess them’ reliability in Brazilian women with metabolic syndrome. Methods: A single-center prospective study with forty elderly postmenopausal women was performed to verify the reliability of indirect calorimetry (IC) versus Bioimpedance (BIA) on RMR fluctuations for an interval length of six months. Results: Measurements showed a high correlation between devices at baseline [BIA vs IC, intraclass correlation coefficient (ICC) ¼ 0.906 (0.822e0.950)]. Surprisingly, a high correlation was kept between BIA and IC after six months [BIA vs. IC, ICC ¼ 0.909 (0.829e0.952)]. The results suggest that both BIA and IC are excellent strategies to measure RMR in elderly postmenopausal women and with metabolic syndrome. Conclusions: However, the BIA method presents greater convenience, optimizes patients’ time, and does not require prolonged fasting to obtain good reliable results compared to IC.
Materias
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
Putative Role of the Aldo-Keto Reductase from Trypanosoma cruzi in Benznidazole Metabolism
Garavaglia, Patricia Andrea; Garavaglia, Patricia Andrea; Garavaglia, Patricia Andrea; Garavaglia, Patricia Andrea; Garavaglia, Patricia Andrea; Laverriere, Marc; Laverriere, Marc; Laverriere, Marc; Laverriere, Marc; Laverriere, Marc; Cannata, Joaquin Juan Bautista; Cannata, Joaquin Juan Bautista; Cannata, Joaquin Juan Bautista; Cannata, Joaquin Juan Bautista; Cannata, Joaquin Juan Bautista; Garcia, Gabriela Andrea; Garcia, Gabriela Andrea; Garcia, Gabriela Andrea; Garcia, Gabriela Andrea; Garcia, Gabriela Andrea (American Society for MicrobiologyAmerican Society for MicrobiologyAmerican Society for MicrobiologyAmerican Society for MicrobiologyAmerican Society for Microbiology, 2016-05)Benznidazole (Bz), the drug used for treatment of Chagas' disease (caused by the protozoan Trypanosoma cruzi), is activated by a parasitic NADH-dependent type I nitroreductase (NTR I). However, several studies have shown ... -
A circunferência do pescoço como marcador da resistência à insulina e síndrome metabólica : BRAMS: Brazilian Metabolic Syndrome Study
Stabe, Christiane França Camargo, 1973 -
Effects of short- and long-term Mediterranean-based dietary treatment on plasma LC-QTOF/MS metabolic profiling of subjects with metabolic syndrome features: The Metabolic Syndrome Reduction in Navarra (RESMENA) randomized controlled trial
Bondia-Pons I.; Martinez J.A.; de la Iglesia R.; Lopez-Legarrea P.; Poutanen K.; Hanhineva K.; Zulet M.D.L.A. (Wiley-VCH Verlag, 2015)